CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Open-market sale CFO, Secretary and Treasurer sold 38,041 shares at $16.44 ($625,394)
- 4 Grant or award Director acquired 11,538 shares (grant or award)
- 4 Grant or award Director acquired 11,538 shares (grant or award)
- 4 Grant or award Director acquired 11,538 shares (grant or award)
- 4 Grant or award Director acquired 11,538 shares (grant or award)
- 4 Grant or award Director acquired 11,538 shares (grant or award)
- 4 Grant or award WEISS MICHAEL S acquired 491,920 shares (grant or award)
- 4 Shares withheld for taxes CFO, Secretary and Treasurer gave up 23,106 shares (to pay taxes)
- 4 Open-market buy WEISS MICHAEL S bought 10,000 shares at $3.43 ($34,300)
- 4 Grant or award Director acquired 8,404 shares (grant or award)
- 4 Grant or award Director acquired 8,404 shares (grant or award)
- 4 Grant or award Director acquired 8,404 shares (grant or award)
- 4 Grant or award Director acquired 8,404 shares (grant or award)
- 4 Grant or award Director acquired 8,404 shares (grant or award)
- 4 Grant or award Director acquired 8,881 shares (grant or award)
- 4 Grant or award Director acquired 8,881 shares (grant or award)
- 4 Grant or award Director acquired 8,881 shares (grant or award)
- 4 Grant or award Director acquired 8,881 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chairman, Interim CEO and Pres acquired 486,743 shares (grant or award)
Page 8 of 18 · 353 filings